Biofilm Formation and Methicillin Resistance of Staphylococcus aureus Isolated from Clinical Samples by Elmanama, Abdelraouf A. et al.




Vol. 10 No. 1:3
doi: 10.3823/841




Background: Staphylococcus aureus including methicillin resistant S. 
aureus (MRSA) is one of the most effective biofilm-forming organisms. 
Biofilm formation contributes in protecting the microorganism from 
host defenses and prevent the effective penetration of antimicrobial 
agents. Also, it is considered as an important contributing factor for 
the initiation and establishment of chronic infection by S. aureus and 
its a major obstacle in the treatment of S. aureus infections.
Aims: To screen clinical Staphylococcus aureus for their biofilm forming 
abilities and their association with antimicrobial resistance.
Methods: A total of 196 clinical isolates of S. aureus were obtained 
from different sample sources using standard microbiological techni-
ques from three major hospitals in Gaza strip. Biofilm formation of 
these isolates was determined by tissue culture plate (TCP) method 
and tube adherence method (TM). Antimicrobial susceptibility test was 
performed using the modified Kirby-Bauer disk diffusion method as 
recommended by Clinical and Laboratory Standards Institute guideli-
nes. MRSA isolates was detected using the cefoxitin disk test.
Results: Biofilm formation was observed in 174 (88.8 %) and in 145 
(74.0%) isolates of S. aureus via TCP method and TM, respectively. 
The highest resistance percent was for penicillin (92.9%), followed by 
cefoxitin (80.6%) and oxacillin (67.9%), while the lowest resistance 
percent was for linezolid and ceftaroline (1%). Among the total 196 
isolates, 140 (71.4%) were classified as MDR with a MAR index (≥ 0.2).
A total of 158 isolates (80.6%) were identified as MRSA distributed 
among hospitals as the following; 90.4%, 79.4% and 70.9% from 
Al-Shifa, Al-Nasser pediatrics and Al-Aqsa hospitals respectively. Lar-
ge proportions (82.1%) of biofilm producers were identified among 
MRSA isolates. Biofilm-producing MRSA exhibited a higher percent 
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Introduction
Staphylococcus aureus is described as Gram-positive 
cocci, facultative anaerobic microorganisms [1]. Cells 
ranging in size from 0.5 to 1.7 μm in diameter. It 
is immotile and is not capable of forming spores. 
Cells are aggregated in clusters that are often des-
cribed as grape-like cluster [2]. Staphylococci are wi-
dely spread colonizers of human epithelia and are 
opportunistic pathogens implicated with various 
health care associated diseases [3-4].
Several predisposing factors to S. aureus infec-
tion including but not limited to; immunocompro-
mised host, invasive procedure that cause damage 
to the skin or mucosal surface such as indwe-
lling medical devices, surgery, hemodialysis. In 
addition, homosexual men and those with close 
contact sports as well as those who live in close 
proximity, are also exposed to Staphylococcal in-
fections [5].
A notable major obstacle in the treatment of S. 
aureus infections is their ability to develop resistan-
ce to antimicrobials. Few decades ago and up to 
this date, the emergence of methicillin resistance S. 
aureus (MRSA) has spread worldwide and is almost 
endemic in most healthcare facilities and is increa-
singly becoming one of the prominent causes of 
death in the United States [6-7].
Biofilms form when bacteria aggregate in com-
munities where cells are embedded in an extrace-
llular polymeric compounds matrix attached to a 
surface [8]. This extracellular matrix is produced by 
the bacteria itself and composed of exopolysac-
charides (EPSs), proteins and other macromolecules 
such as DNA [9]. Biofilm contribute in protecting 
the microorganism from host defenses and prevent 
the effective penetration of antimicrobial agents 
[10].
A wide range of bacterial pathogens produce and 
persist in biofilms. S. aureus is one of the most 
effective biofilm-forming organisms [11]. The ability 
of biofilm formation is considered as an important 
contributing factor for the initiation and establish-
ment of chronic infection by S. aureus [12]. Biofilm 
formation by S. aureus may lead to the delay of 
re-epithelialization of the infected tissues, leading 
to increased healing time [13].
It is not fully known whether S. aureus biofilm 
forming ability qualify it to colonize/infect certain 
(90.5%) when compared with the biofilm non-producer MRSA (9.5%). 
Importantly, 89.2% of biofilm-producing S. aureus were multidrug 
resistant.
Conclusions: S. aureus isolates possessed high biofilm-forming ability 
and very high tendency to exhibit antimicrobial resistance, multidrug 
resistance and methicillin resistance. Regular surveillance of biofilm 
formation by S. aureus and their antimicrobial resistance profile may 
lead more success in treating S. aureus infections.
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sites or tissues. In addition, correlating biofilm for-
ming ability to antimicrobial resistance is necessary 
in the battle of combating S. aureus and its drug 
resistance.
Materials and Methods
Sample Collection and Processing
A total of 196 isolates were collected from three 
major hospitals (Al-Shifa, Al-Aqsa and Al-Nasser 
Pediatrics hospitals) from different departments 
and different sites of infection. Isolates were obtai-
ned from the microbiology department along with 
patient’s data. 
The sampling period started from April 2018 and 
continued for eight months. All isolates were transfe-
rred to Islamic University of Gaza (IUG) Microbiology 
Research laboratory. Each isolate was then streaked 
onto the surface of Blood Agar and Mannitol Salt 
Agar plates and incubated for 24 hours at 37°C for 
purity check and identification purposes. Glycerol 
with Brain Heart Infusion Broth (BHIB) were used 
for long-term storage of isolates.
S. aureus identification
After the incubation period, colonies were identified 
based on colony color and morphology in addition 
to Gram stain and the final identification was per-
formed using conventional biochemical tests (e.g, 
catalase, coagulase, and DNase test). Only confir-
med S. aureus isolates werefurther tested.
Antimicrobial susceptibility testing
The susceptibilities of the isolates to ceftaroli-
ne, cefoxitin, chloramphenicol, ciprofloxacin, cla-
rithromycin, clindamycin, gentamicin, linezolid, 
oxacillin, penicillin, rifampicin, tetracycline and 
trimethoprim-sulfamethoxazole, were determined 
using the disk diffusion method according to the 
quidelines and interpretive criteria of the Clinical 
and Laboratory Standards Institute (CLSI) [14]. A 
0.5 McFarland standardized inoculum was spread 
using cotton swab onto the surface of two Muller 
Hinton (MH) agar plates. The appropriate antimi-
crobial disks were applied and plates were transfe-
rred to a refrigerator for 30 minutes and then was 
incubated for 24 hours at 37oC. The zone of inhi-
bition was measured and interpreted as sensitive, 
resistant or intermediate according to the CLSI. 
Tissue culture plate method
A single colony of S. aureus was picked from an 
overnight-incubated Blood agar plate and inocula-
ted into 2 mL of BHIB supplem ented with 0.25% 
(wt/vol) glucose (15). The broth was incubated over-
night at 37 °C. The culture was then diluted 1:100 
with fresh medium. A sterile individual well in 96 
flat-bottom polystyrene wells was filled with 200 
μL of the diluted culture. Negative control contai-
ned broth only and a Positive control (A control 
strain of biofilm forming S. aureus (ATCC: 6538) 
was used. The control strain was also processed in 
a similar manner. The plate was incubated at 37 °C 
for 72 hours. After incubation, the content of each 
well was removed. Each well was washed three ti-
mes with 250 μl of DW. After 15 min, plates were 
stained for 5 min with 0.2 ml of 2% crystal violet 
per well. Excess stain was removed and rinsed off 
by placing the plates under running tap water. The 
plates were air-dried.
The adherent cells were re-solubilized with 160 
μl pure methanol per well [16]. The optical density 
of each was measured at 570 nm. Results interpre-
ted according to the followings criteria; OD <0.5 
(negative), OD ≥ 0.5 (positive) (17). Wells containing 
only sterile BHIB served as a background control; 
their average absorbance value was subtracted 
from all experimental readings [15]. 
Tube adherence method
An aliquot of 0.1 mL of bacterial culture (obtained 
by adjusting turbidity to 0.5 McFarland standards) 
The InTernaTIonal arabIc Journal of anTImIcrobIal agenTs 
ISSN: 2174-9094
2020
Vol. 10 No. 1:3
doi: 10.3823/841
This article is available at: www.iajaa.org4
was transferred to glass test tube containing 10 mL 
BHIB which was incubated at 37°C for 72 hours.
The medium was then removed and the tubes 
were washed with distilled water, air dried and bio-
film formation were assayed by 2% crystal violet 
[16]. Visible lining of the wall and bottom of the 
tube by presence of a film were considered as po-
sitive.
Data analysis
Collected data were summarized, tabulated and 
analyzed using Statistical package for Social Scien-
ces (SPSS) software. Chi square test was used to 
detect significant differences among hospitals and 
or samples. The results are presented as tables and 
figures.
Results
A total of 196 S. aureusclinical isolates were co-
llected from Al-Shifa (N=83), Al-Nasser pediatrics 
(N=34) and Al-Aqsa (N=79) hospitals. One hundred 
forty-four isolates (73.5%) were obtained from male 
patients and the remaining 52 (25.5%) were from 
female patients.
All the isolates were obtained from clinical 
samples, collected from different sources The pus 
group includes pus from different sources, wound 
and ear charge samples (N=171), while the body 
fluids group contains urine, blood, plural and ce-
rebrospinal fluied (N=10). The group labelled as 
"Others" contain sputum, bone, skin and soft tis-
sue samples (N=15).
Antimicrobial susceptibility test
As shown in Table 1, the highest resistance rate 
was against penicillin G (92.9%), followed by ce-
foxitin (80.6%) and oxacillin (67.9%); both of which 
are used to detect methicillin resistance, while the 
lowest resistance rate was against linezolid and ce-
ftaroline (1%)
Out of 13 antimicrobials used in this study, pini-
cillin G had the lowestt activity in all three hospitals 
in the study as showen in Table 2. Chi sqaure statis-
tical analysis showed significanct differences among 
hospitals with regard to resistance against several 
antibiotics (P value ≤ 0.05) with Al-shifa hospital 
showing the highest resistance rate for most of the 
tested antimicrobials.
Multiple Antibiotc Resistance index 
(MARI) and multidrug resistance 
MAR index was calculated for each isolates by divi-
ding the number of antibiotics that the isolate was 
resistsnce to by the number of all antibiotics which 
the isolates was tested for. Any isolate with an index 
of more than 0.2 is considered as MDR. Among the 
196 isolates, 71.4% (N=140) were classified as MDR 
with a MAR index (≥0.2).
MRSA and MSSA
To identify MRSA, cefoxiten antibiotic disks were used, 
80.6% of the isolates were resistant to cefoxitin. The 
highest resistance to cefoxitin was found at Al-Shiffa 
hospital 90.4% followed by Al-Nasser pediatrics hos-
pital (79.4%) and Al-Aqsa hospital (70.9%)
Table 1.  Antimicrobial susceptibility profil of 196 S. 
aureus against 13 antimicrobials.
Antimicrobial
Sensitive Intemediate Resistant
No. % No. % No. %
Ceftaroline 184 93.9 10 5.1 2 1.0
Cefoxitin 38 19.4 0 0.0 158 80.6
Chloramphenicol 169 86.2 3 1.5 24 12.2
Ciprofloxacin 142 72.4 13 6.6 41 20.9
Clarithromycin 126 64.3 8 4.1 62 31.6
Clindamycin 168 85.7 5 2.6 23 11.7
Gentamicin 145 74.0 1 0.5 50 25.5
Linezolid 194 99.0 0 0.0 2 1.0
Oxacillin 40 20.4 23 11.7 133 67.9
PenicillinG 14 7.1 0 0.0 182 92.9
Rifampicin 175 89.3 5 2.6 16 8.2
Tetracycline 122 62.2 5 2.6 69 35.2
Trimethoprim-
sulfamethoxazole
143 73.0 12 6.1 41 20.9
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Table 3.  Biofilm production using Tissue Culture Plate Method and Tube Method according to hospitals, 
specimen source and departments .
Tissue Culture Plate Method
P- value
Tube Method
P- valuePositive Negative Positive Negative
No. % No. % No. % No. %
Hospital
Al-Aqsa 65 82.3 14 17.7
0.055*
53 67.1 26 32.9
0.184Al-Shiffa 78 94.0 5 6.0 66 79.5 17 20.5
Al-Nasser 31 91.2 3 8.8 26 76.5 8 23.5
Specimen source
Pus 149 87.1 22 12.9
0.163
123 71.9 48 28.1
0.124Body fluids 10 100 0 0.0 10 100 0 0.0
Other 15 100 0 0.0 12 80.0 3 20
Department 
Pediatrics 14 87.5 2 12.5
0.994
12 75.0 4 25.0
0.691
Out patients 54 88.5 7 11.5 45 73.8 16 26.2
Nursury 30 90.9 3 9.1 27 81.8 6 18.2
Surgury 59 88.1 8 11.9 49 73.1 18 26.9
Other 17 89.5 2 10.5 12 63.2 7 36.8












%(N=79) % (N=83) % (N=34)
Ceftaroline 0.0 2.4 0.0 0.012*
Cefoxitin 70.9 90.4 79.4 0.007*
Chloramphenicol 11.4 16.9 2.9 0.228
Ciprofloxacin 13.9 33.7 5.9 0.002*
Clarithromycin 39.2 31.3 14.7 0.051*
Clindamycin 11.4 15.7 2.9 0.310
Gentamicin 11.4 43.4 14.7 0.000*
Linezolid 2.5 0.0 0.0 0.224
Oxacillin 59.5 77.1 64.7 0.025*
Penicillin G 93.7 94.0 88.2 0.514
Rifampicin 7.6 8.4 8.8 0.131
Tetracycline 29.1 45.8 23.5 0.009*
Trimethoprim-
sulfamethoxazole
29.1 13.3 20.6 0.125
*: Statistically significant.
Biofilm results
Among 196 isolates, 88.8 % (N=174) were bio-
film producers, while only 11.2% (N=22) did not 
show biofilm formation by the Tissue Culture Plate 
method. The biofilm-producing isolates percenta-
ge in Al-Shiffa hospital was 94.0%, while the per-
centage was 82.3% and 91.2% in Al-Aqsa and 
Al-Nasser Pediatics hospitals respectively. Biofilm 
formation was 100% positve in all specimen type 
except pus, the percent was (87.1%).
About 74.0% (N=145) of the isolates were bio-
film producers by the Tube Method distributed 
among hospitals (79.5%),(67.1%), (76.5%) for Al-
Shiffa, Al-Nasser pediatrics and Al-Aqsa hospitals 
respectively. The biofilm formation was 100% in 
the specimens that comes from body fluids while 
it was (71.9%) in the pus group and (80.0%) in the 
other specimen types as presented in Table 3.
Biofilm and antimicrobial resistance
Table 4 showes the biofilm forming ability versus 
antimicrobial resistance. For all the antimicrobialsu-
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sed, the majority of the resistant strains was biofilm 
producers but the results don't reach statistically 
significant level.
A total of 125 (89.2%) MDR isolates were biofilm 
producers while the remaining 15 isolates (10.7%) 
were non-biofilm producers as presented in Table 
5. (No statistical significant differnce was found).
Among the 158 (80.6%) isolates identified as 
MRSA, 143 (90.5%) isolates were biofilm producers 
as shown in Table 6. (No statistically significance 
differnce was found). 
Disscusion
All S. aureus isolates examined in this study were at 
least resistance to one of the 13 antimicrobials tes-
ted. The lowest antimicrobial resistanc was 1.0% for 
both ceftaroline and linezolid, however, these two 
antimicrobials are not used in treatment protocols 





No. % No. %
Ceftaroline
R 2 100 0 0.0 2
0.446S 162 88.0 22 12.0 184
I 10 100 0 0 10
Cefoxitin
R 143 90.5 15 9.5 158
0.007*
S 31 81.6 7 18.4 38
Chloramphenicol
R 21 87.5 3 12.5 24
0.811S 150 88.8 19 11.2 169
I 3 100 0 0.0 3
Ciprofloxacin
R 37 90.2 4 9.8 41
0.847S 125 88.0 17 12.0 142
I 12 92.3 1 7.7 13
Clarithromycin
R 54 87.1 8 12.9 62
0.552S 112 88.9 14 11.1 126
I 8 100.0 0 0.0 8
Clindamycin
R 18 78.3 5 21.7 23
0.184S 151 89.9 17 10.1 168
I 5 100.0 0 0.0 5
Gentamicin
R 45 90.0 5 10 50
0.888S 128 88.3 17 11.7 145
I 1 100.0 0 0.0 1
Linezolid
R 2 100 0 0.0 2
0.613
S 172 88.7 22 11.3 194
Oxacillin
R 119 89.5 14 10.5 133
0.675S 34 85.0 6 15.0 40
I 21 91.3 2 8.7 23
Penicillin G
R 160 87.9 22 12.1 182
0.167
S 14 100 0 0.0 14
Rifampicin
R 15 93.8 1 6.3 16
0.567S 154 88.0 21 12.0 175
I 5 100 0 0.0 5
Tetracycline
R 62 89.9 7 10.1 69
0.118S 109 89.3 13 10.7 122
I 3 60.0 2 40.0 5
Trimethoprim-
sulfamethoxazole
R 34 82.9 7 17.1 41
0.406S 129 90.2 14 9.8 143
I 11 91.7 1 8.3 12





No. % No. %
0.07 11 73.3 4 26.7 15
0.113
0.1 38 92.7 3 7.3 41
0.2 40 83.3 8 16.7 48
0.28 39 97.5 1 2.5 40
0.3 21 87.5 3 12.5 24
0.4 13 100.0 0 0.0 13
0.5 2 100.0 0 0.0 2
0.57 6 75.0 2 25.0 8
0.6 1 100.0 0 0.0 1
0.7 2 100.0 0 0.0 2
0.78 1 50.0 1 50.0 2





No. % No. %
MSSA 31 81.6 7 18.4
0.0.118
MRSA 143 90.5 15 9.5
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in Gaza strip hospitals and are not available in the 
local drug market.
Linezolid is a worldwide effective and well tole-
rated antimicrobial in patients with S. aureus infec-
tions. In a study done in Nepal, linezolid showed the 
highest rate of susceptibility (100%) [18]. In other 
study done in Cleveland showed that there is an 
10.4% emergence of linezolid-resistant S. aureus 
after prolonged treatment of cystic fibrosis [19]. 
Thus, linezolid should be considered in treatining 
MRSA infections.
The highest resistance rate was for penicillin 
(92.9%), this rate is higher than the percents con-
ducted in two studies in 2016 and 2017 that was 
65.9% and 62% respectively, in Gaza Strip [20-
21], and was lower than Elbayoumi study that 
done in 2011, the resistance percent for penicillin 
was 100% [22] and Hujir study in 2006 (94.0%) 
[23].
Also oxacillin resistance percent in this study was 
higher than the result obtained in tow previous 
studies done in 2006 and one study in 2017 [21-
23]. These variations could be explained by the 
variation of sample size, types of samples tested 
and of course by the specific area covered by these 
studies. 
The rate of resistance for trimethoprim-sulfa-
methoxazole, ciprofloxacin and chloramphenicol 
was higher than the percent in Elmanama study 
in 2016 [20].On the other hand, the resistance to 
rifampicin and clindamycin was lower than that in 
2006 and 2016 (20-23). This increase in the suscep-
tibility for these antimicrobial may be due to the 
limited prescription and use in the treatment pro-
cedure during the recent years.
The increase in the antibitics resistance rates in 
this study could be due to the excessive use, misuse 
and the absence of restriction on the prescription 
of these antibiotics in Gaza strip [24].
For most antimicrobials tested in the study, Al-
Shiffa hospital demonstrated the highest rate of 
resistance, the differences between hospitals may 
be due to the differences in the treatment protocols 
between them, the varied level of commitment of 
infection control measures and procedures and the 
high number of patients. 
Eight of the 13 antibiotics tested in the study 
showed the highest rate of resistance in the sur-
gury department, with a staistically significant level 
for ciprofloxacin (P=0.01), gentamycin (P=0.030) 
and tetracyclin (P= 0.048). This may be due to the 
excessive use of these antimicrobial agents in the 
surgury departments in Gaza Strip hospitals with 
the absence of clear guidelines. Therefore, it's very 
important to focus on the choice and duration of 
antimicrobials agents that used either as pre or 
post operative prophylaxis or post infection [6].
For detecting MRSA,cefoxitin disk was used 
rather than methicillin and oxacillin because cefoxi-
tin would overcome the failure of routine oxacillin 
disks to detect heterogeneous MRSA, it is a good 
indicator of pinicillin binding protein 2a in S. aureus 
isolates that carry mecA gene [21]. Therefore, tes-
ting of cefoxitin give more reproducible and accu-
rate results than testing with methicillin or oxacillin. 
This fact was eveident by the results of this study 
where oxacillin resistance rate was 67.9% while ce-
foxitin was higher (80.6%).
The overall MRSA percent in this study was 
80.6% and this is higher than the results of study 
conducted in 2006 in Gaza strip which was only 
22% [23], and higher than another study done 
in 2015 (56.3%) [25]. In 2017, MRSA percent in 
southern "Israel" was 40% [26], while in other 
neighboring countries like Egypt, Jordan and Le-
banon MRSA percent was 52%, 56% and 30% 
respectively [27].
This increase in MRSA percent in Gaza strip in this 
study over the last decade maybe due to the pre-
sence of high percent of health care worker carrying 
MRSA according to study done in 2017 [14], the 
weak infection control procedur and the absence 
of protocols for diagnosis, detection and quarantine 
for MRSA patients in Gaza Strip hospitals.
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High percent of MRSA was found in pediatric 
departments (93.8%) and surgery departments 
(85.1%). In a study done in Gaza Strip hospitals 
in 2017 for detecting nasal carrige MRSA among 
health care worker the highest percent of MRSA 
was in surgery department (35%) [21]. This high re-
sistance rate in these departments may be due the 
crowdeness, high work load, weak infection control 
procedure and shortage of stuff.
The prevalence of biofilm formation varied bet-
ween the two testing methods (88.8% and 74.0% 
(TCP and TM). Also, there was a little variation bet-
wen the two methods used by a study in Nepal, 
where biofilm formation was (69.8%) and (65.1%) 
for TCP and TM, respectivily [28].
Tube method is an easy and low cost test, but it's 
less accurate than TCP method because it depends 
on the personal observation (visual inspection) as 
a qualitaive methode, it can be used as screning 
test for biofilm formation. While TCP method is a 
qantitative method that can detect even the weak 
biofilm producer strains [28].
The present study, shows that the biofilm-produ-
cing isolates were associated with higher incidence 
of antimicrobial resistance when compared with 
non-producer isolates. In addition, the major rate 
of the MDR isolates were biofilm producer (89.2%), 
particularly among the isolates that were identified 
as MRSA (90.5%). However, theses differences did 
not reach a statistically significant level.
These results is concordant with a study done in 
Nepal (2018) concluded that higher rate of antimi-
crobial resistance is demonstrated among biofilm 
producers than in biofilm nonproducers. The bio-
film-positive strains have a higher tendency to ex-
hibit multidrug resistance and methicillin resistance 
compared to biofilm-negative strains [28]. Another 
study showed that 97.5% of biofilm producers from 
burn wound samples were MRSA [29]. A study done 
in Spain, found that all the staphylococcal isolates 
that produced biofilm except one harbor horizontal 
transfer of antibiotic resistance genes [30].
In addition, our results is concordant with Be-
lbase study in Nepal that showed higher rates 
of multidrug resistance and methicillin resistance 
were found among biofilm-producing isolates in 
comparison to biofilm non-producing isolates [18]. 
Also, a recent study from Jordan, has demonstra-
ted that most MRSA strains can produce biofilm, 
and one methicillin-sensitive S. aureus (MSSA) iso-
late typed as spa t955 showed biofilm formation 
potential through protein deposition [31]. There-
fore, we suggest that biofilm forming capacity of 
MRSA strains are important factor in developing 
infection. 
Conclusion
The findings in this study demonstrated that hig-
her rates of antimicrobialresistance areexhibited by 
biofilm producers than by nonproducers biofilm 
isolates. The biofilm-positive strains have a higher 
tendency to exhibit multidrug resistance than by 
nonproducers biofilm isolates. In addition, among 
MRSA isolates, the majority were biofilm producer. 
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